The provisions of Section 11 of the Electronic Communications and Transactions Act 25 of 2002 apply to this email notice and make it enforceable and binding on the recipient/addressee.
This email message (including attachments) contains information which may be confidential and/or legally privileged. Unless you are the intended recipient, you may not use, copy or disclose to anyone the message or any information contained in the message or from any attachments that were sent with this email, and If you have received this email message in error, please advise the sender by email, and delete the message. Unauthorised disclosure and/or use of information contained in this email may result in civil and criminal liability.
Everything in this e-mail and attachments relating to the official business of PHARMED PHARMACEUTICALS PTY LTD is proprietary to the company.
Caution should be observed in placing any reliance upon any information contained in this e-mail, which is not intended to be a representation or inducement to make any decision in relation to PHARMED. Any decision taken based on the information provided in this e-mail, should only be made after consultation with appropriate legal, regulatory, tax, technical, business, investment, financial, and accounting advisors.
The e-mail address of the sender may not be used, copied, sold, disclosed or incorporated into any database or mailing list for spamming and/or other marketing purposes without the prior consent of PHARMED. Neither the sender of the e-mail, nor PHARMED shall be liable to any party for any direct, indirect or consequential damages, including, without limitation, loss of profit, interruption of business or loss of information, data or software or otherwise.
No warranties are created or implied that an employee of PHARMED and/or a contractor of Internet solutions is authorized to create and send this e-mail.